Release Date: 28/02/18 16:39 Summary: Appendix 4D Half Year Report Price Sensitive: Yes Download Document 1.56MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%